Pure speculation on my part.
Dr. Lauren Chung is just brought on board to TODOS
Same Dr. Chung is a Director at CURE
https://curepharmaceutical.com/about/board-of-directors
CURE Pharmaceutical is a vertically-integrated drug delivery and development company with a proprietary formulation and delivery platform called CUREform™.
CUREform™ includes our signature oral dissolvable film, CUREfilm®, a patented oral thin film formulation that makes medications easier to take, more efficacious, with improved tolerability and fewer side effects.
We are DEA-Licensed and FDA-registered:
We develop and manufacture our CUREform™ products in Oxnard, CA. Our manufacturing facility is one of the first in the United States to receive a Schedule 1 license from the United States Drug Enforcement Administration (DEA). We are also registered with the United States Food and Drug Administration (FDA) and are a cGMP facility, committed to Current Good Manufacturing Practice regulations as enforced by the FDA.
https://curepharmaceutical.com
The tie in that I see, from my background, patients that have a difficult time or inability to swallow, this together could be an breakthrough solution.
Seems like a good fit in some way or another.
Emerald Organic Products, Inc. Announces Exclusive Licensing Agreement With PetVivo Holdings Inc.
August 05, 2019 09:55 ET | Source: Emerald Organic Products Inc.
New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) (“Emerald” or the “Company”) is pleased to announce that it has formally entered into an exclusive licensing agreement for the use of OraPatch™, a patented oral delivery method for various substances including caffeine and cannabidiol (“CBD”) from PetVivo Holdings, Inc. (OTC
ETV) (“PetVivo”).
The patented oral adhesion technology, OraPatch™, is a slowly degradable protein wafer-disc that attaches to and assimilates with the mouth's inner lining. PetVivo is the holder of patents for this unique and cutting-edge method for nutraceutical and supplement delivery.
The fully dissolving wafer-like invention sticks strongly and comfortably the roof of the mouth, cheeks, or gums. This delivery method provides both a rapid release and greater bioavailability when compared to ingestion. Furthermore, the OraPatch product only uses materials deemed to be Generally Recognized as Safe (“GRAS”) by the United States Food and Drug Administration (the “FDA”).
“The potential introduction of this technology to our line of products can change the entire dynamics and approach to both our vitamin and nutraceuticalmarkets, especially for our flagship PURA CBD products” said Emerald Organic Products, Inc. CEO, Ian Parker.
John Lai, President of PetVivo said, “We were waiting for the right consumer branding team to license this extraordinary, cutting edge technology to. Clearly, the management pedigree of Emerald is best-in-class in the emerging cannabinoid market.” Lai continued, “In the right hands, this product has the potential to revolutionize the vitamin and CBD market place and we are confident we found the right team partner in Emerald.”
Using safe materials, the efficiency afforded by this new patented delivery technology may allow for enhanced bioavailability and efficacy while employing lower and more exact product doses, thereby reducing potential stomach irritations and risks of toxicity.
“There is no delivery system like it in the market. The potential use of this brand new delivery method breakthrough, known as the “OraPatch” can create a paradigm shift in the way CBD and other cannabinoids are delivered to and ingested by consumers,” added Parker. “OraPatch has applications that will uniquely distinguish Emerald as a category leader in the CBD market. No other brand will be able to match our industry recognized top quality product combined with our newly acquired patented delivery system that has applications to so many highly profitable market segments”
https://www.globenewswire.com/news-release/20...s-Inc.html
Dr. Lauren Chung is just brought on board to TODOS
Same Dr. Chung is a Director at CURE
https://curepharmaceutical.com/about/board-of-directors
CURE Pharmaceutical is a vertically-integrated drug delivery and development company with a proprietary formulation and delivery platform called CUREform™.
CUREform™ includes our signature oral dissolvable film, CUREfilm®, a patented oral thin film formulation that makes medications easier to take, more efficacious, with improved tolerability and fewer side effects.
We are DEA-Licensed and FDA-registered:
We develop and manufacture our CUREform™ products in Oxnard, CA. Our manufacturing facility is one of the first in the United States to receive a Schedule 1 license from the United States Drug Enforcement Administration (DEA). We are also registered with the United States Food and Drug Administration (FDA) and are a cGMP facility, committed to Current Good Manufacturing Practice regulations as enforced by the FDA.
https://curepharmaceutical.com
The tie in that I see, from my background, patients that have a difficult time or inability to swallow, this together could be an breakthrough solution.
Seems like a good fit in some way or another.
Emerald Organic Products, Inc. Announces Exclusive Licensing Agreement With PetVivo Holdings Inc.
August 05, 2019 09:55 ET | Source: Emerald Organic Products Inc.
New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) (“Emerald” or the “Company”) is pleased to announce that it has formally entered into an exclusive licensing agreement for the use of OraPatch™, a patented oral delivery method for various substances including caffeine and cannabidiol (“CBD”) from PetVivo Holdings, Inc. (OTC
ETV) (“PetVivo”). The patented oral adhesion technology, OraPatch™, is a slowly degradable protein wafer-disc that attaches to and assimilates with the mouth's inner lining. PetVivo is the holder of patents for this unique and cutting-edge method for nutraceutical and supplement delivery.
The fully dissolving wafer-like invention sticks strongly and comfortably the roof of the mouth, cheeks, or gums. This delivery method provides both a rapid release and greater bioavailability when compared to ingestion. Furthermore, the OraPatch product only uses materials deemed to be Generally Recognized as Safe (“GRAS”) by the United States Food and Drug Administration (the “FDA”).
“The potential introduction of this technology to our line of products can change the entire dynamics and approach to both our vitamin and nutraceuticalmarkets, especially for our flagship PURA CBD products” said Emerald Organic Products, Inc. CEO, Ian Parker.
John Lai, President of PetVivo said, “We were waiting for the right consumer branding team to license this extraordinary, cutting edge technology to. Clearly, the management pedigree of Emerald is best-in-class in the emerging cannabinoid market.” Lai continued, “In the right hands, this product has the potential to revolutionize the vitamin and CBD market place and we are confident we found the right team partner in Emerald.”
Using safe materials, the efficiency afforded by this new patented delivery technology may allow for enhanced bioavailability and efficacy while employing lower and more exact product doses, thereby reducing potential stomach irritations and risks of toxicity.
“There is no delivery system like it in the market. The potential use of this brand new delivery method breakthrough, known as the “OraPatch” can create a paradigm shift in the way CBD and other cannabinoids are delivered to and ingested by consumers,” added Parker. “OraPatch has applications that will uniquely distinguish Emerald as a category leader in the CBD market. No other brand will be able to match our industry recognized top quality product combined with our newly acquired patented delivery system that has applications to so many highly profitable market segments”
https://www.globenewswire.com/news-release/20...s-Inc.html
3
